Patna doc develops drug to combat diabetes
Good news for diabetics. A Patna doctor has helped develop Liraglutide, a new anti-diabetic drug, which got the approval of the Food and Drug Administration in the US for clinical use on Tuesday.
Read more on The Times of India
Study: Overweight Adults Over 70 May Live Longer
A new study by Australian researchers finds that overweight adults over 70 tend to outlive their thinner — and much fatter — peers
Read more on Time.com via Yahoo! News
Novo Nordisk’s Victoza(R) Receives FDA Approval for Adults With Type 2 Diabetes
PRINCETON, NJ–(Marketwire – January 26, 2010) – Novo Nordisk ( NYSE : NVO ) announced that the U.S. Food and Drug Administration (FDA) approved the new drug application for Victoza® (liraglutide [rDNA origin] injection), the first once-daily human glucagon-like peptide-1 (GLP-1) analog for the treatment of type 2 diabetes. Victoza is indicated as an adjunct to diet and exercise to improve blood …
Read more on Marketwire
S.Korea says N.Korea is not about to collapse
North Korean leader Kim Jong-Il has partially recovered his health and his country is not close to collapse despite grave economic problems, South Korean President Lee Myung-Bak says.
Read more on AFP via Yahoo! News
Johns Hopkins Nursing Research – Winter 2010
Faculty at the Johns Hopkins University School of Nursing (JHUSON) share their latest research, from diabetes to simulation education.
Read more on Newswise
[...] Michael_lambert wrote an interesting post today. Here’s a quick excerptNovo Nordisk’s Victoza(R) Receives FDA Approval for Adults With bType 2 Diabetes/b PRINCETON, NJ–(Marketwire – January 26, 2010) – Novo Nordisk ( NYSE : NVO ) announced that the U.S. Food and Drug Administration (FDA) approved the new drug … [...]